Cleared Traditional

K991402 - DAKO MOUSE ANTI-HUMAN T-CELL, CD3/RPE-CY5, CLONE UCHT1 & DAKO MOUSE ANTI-HUMAN T-CELL, CD3/RPE, CLONE UCHT1
(FDA 510(k) Clearance)

Jun 1999
Decision
60d
Days
Class 2
Risk

K991402 is an FDA 510(k) clearance for the DAKO MOUSE ANTI-HUMAN T-CELL, CD3/RPE-CY5, CLONE UCHT1 & DAKO MOUSE ANTI-HUMAN T-CELL, CD3/RPE, CLONE UCHT1. This device is classified as a Counter, Differential Cell (Class II - Special Controls, product code GKZ).

Submitted by Dako Corp. (Carpinteria, US). The FDA issued a Cleared decision on June 21, 1999, 60 days after receiving the submission on April 22, 1999.

This device falls under the Hematology FDA review panel. Regulated under 21 CFR 864.5220.

Submission Details

510(k) Number K991402 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 22, 1999
Decision Date June 21, 1999
Days to Decision 60 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF

Device Classification

Product Code GKZ — Counter, Differential Cell
Device Class Class II - Special Controls
CFR Regulation 21 CFR 864.5220